LOC100129216 Activators
Chemical activators of LOC100129216 utilize various intracellular signaling pathways to modulate the activity of this protein. Epinephrine and forskolin, for instance, both act to increase intracellular cAMP levels, albeit through different mechanisms. Epinephrine binds to adrenergic receptors and triggers the activation of adenylate cyclase, which converts ATP to cAMP. Forskolin directly stimulates adenylate cyclase without the need for receptor activation. The rise in cAMP activates protein kinase A (PKA), which then phosphorylates LOC100129216, assuming it is within the substrate profile of PKA. Similarly, the cAMP analogs, 8-Bromo-cAMP and Dibutyryl cAMP, permeate cells and directly activate PKA, leading to the phosphorylation and activation of LOC100129216.
In contrast to these cAMP-dependent pathways, other chemicals act through different kinase pathways or mechanisms to influence the phosphorylation state of LOC100129216. Ionomycin raises intracellular calcium levels, thereby activating calcium-dependent kinases that can phosphorylate LOC100129216. Thapsigargin also increases cytosolic calcium by inhibiting SERCA, which has a similar activating effect on calcium-dependent kinases. PMA activates protein kinase C (PKC), which phosphorylates serine and threonine residues on its substrates, including potentially LOC100129216. Calyculin A inhibits the action of protein phosphatases 1 and 2A, leading to increased phosphorylation levels of proteins, which could result in the activation of LOC100129216. Zinc Pyrithione releases zinc ions, which can activate protein kinases that may target LOC100129216. Lastly, Bisindolylmaleimide I, while primarily known as a PKC inhibitor, can induce the activation of alternative kinases, which in turn can phosphorylate LOC100129216, if it is a suitable target. These diverse chemicals, through their unique modes of action, all converge on the common endpoint of modulating the phosphorylation state and consequent activation of LOC100129216.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine, through its interaction with adrenergic receptors, leads to the activation of adenylate cyclase and subsequent increase in cAMP. Elevated cAMP activates PKA, which can phosphorylate and activate LOC100129216, assuming LOC100129216 is a substrate for PKA. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent protein kinases. These kinases can phosphorylate and activate LOC100129216, given that LOC100129216 is phosphorylated by such kinases. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate serine and threonine residues on target proteins. If LOC100129216 is a PKC substrate, its activation could be directly mediated by PKC phosphorylation. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A inhibits protein phosphatases 1 and 2A, preventing the dephosphorylation of proteins. This results in increased phosphorylation and activation of proteins, including LOC100129216, if it is normally regulated by these phosphatases. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to elevated cytosolic calcium levels, which activates calcium-dependent protein kinases. If LOC100129216 is a target of these kinases, thapsigargin would activate LOC100129216 through this mechanism. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc Pyrithione facilitates the release of zinc ions, which can act as signaling molecules. Zinc ions can activate protein kinases that may phosphorylate and activate LOC100129216 if it is a target of such kinases. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that activates stress-activated protein kinases (SAPKs). These kinases can phosphorylate and activate LOC100129216, assuming LOC100129216 is a substrate for SAPKs. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that activates PKA. PKA can phosphorylate and activate LOC100129216, provided that LOC100129216 is a PKA substrate. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl cAMP, another cell-permeable cAMP analog, activates PKA, which can then phosphorylate and activate LOC100129216 if it is a target of PKA. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a potent and selective inhibitor of PKC, but its action can lead to compensatory activation of other kinases that may phosphorylate and activate LOC100129216, assuming it is a substrate for such kinases. | ||||||